Giulia Ambrosi - Concepedia

Author

Giulia Ambrosi

Fondazione Istituto Neurologico Nazionale Casimiro Mondino

Also Known As

Ambrosi, Giulia, G AMBROSI, G Ambrosi, G. Ambrosi, GIULIA AMBROSI, Giulia Ambrosi

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Fondazione Istituto Neurologico Nazionale Casimiro Mondino Istituti di Ricovero e Cura a Carattere Scientifico University of Pavia German Cancer Research Center Heidelberg University

About

Giulia Ambrosi is an author at Fondazione Istituto Neurologico Nazionale Casimiro Mondino specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	573
2	Social Sciences	4	4	136
3	Health Sciences	2	2	42
4	Biochemistry	1	1	98
5	Biomolecular Engineering	1	1	45

Giulia Ambrosi

Publications

861

Citations

H-Index

Page 1

	Year	Citations
MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer Tianzuo Zhan, Giulia Ambrosi, Anna Maxi Wandmacher, Nature Communications	2019	183
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells Giulia Ambrosi, Cristina Ghezzi, Roberta Zangaglia, Neurobiology of Disease MitophagyBiochemistryAmbroxol-induced RescueGba1 Mutant ParkinsonGlycobiology	2015	98
DJ-1 knock-down impairs astrocyte mitochondrial function Niccole J. Larsen, Giulia Ambrosi, Steven J. Mullett, Neuroscience Molecular NeuroscienceMitochondrial FunctionMitochondrial DynamicAutophagyCell Death	2011	85
Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease Giulia Ambrosi, Cristina Ghezzi, Sara Sepe, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease FibrosisSporadic ParkinsonParkinson DiseasePathologyProteolytic Defects	2014	63
Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease Giulia Ambrosi, Marie‐Thérèse Armentero, Giovanna Levandis, Brain Research Bulletin Motor ImpairmentNeurophysiologyMglur5 AntagonistParkinson DiseaseMedicine	2010	49
gscreend: modelling asymmetric count ratios in CRISPR screens to decrease experiment size and improve phenotype detection Katharina Imkeller, Giulia Ambrosi, Michael Boutros, Genome biology	2020	49
Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease Marie‐Thérèse Armentero, Elena Sinforiani, Cristina Ghezzi, Neurobiology of Aging Key Regulatory KinasesAlzheimer's DiseaseSignal TransductionReceptor Tyrosine KinaseAutophagy	2010	48
Modified Acidic Nonsteroidal Anti-Inflammatory Drugs as Dual Inhibitors of mPGES-1 and 5-LOX Mahmoud Elkady, Raimund Nieß, Anja Schaible, Journal of Medicinal Chemistry ImmunologyPharmacotherapyPharmaceutical ChemistryInflammationMolecular Pharmacology	2012	45
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat Giulia Ambrosi, Nataša Kuštrimović, Francesca Siani, Neurotoxicity Research Nigrostriatal Pathway InducedMedicineImmunologyBrain-immune InteractionNeuroprotection	2017	44
Neuroprotective Potential of Adenosine A<sub>2A</sub>and Cannabinoid CB<sub>1</sub>Receptor Antagonists in an Animal Model of Parkinson Disease Silvia Cerri, Giovanna Levandis, Giulia Ambrosi, Journal of Neuropathology & Experimental Neurology Nondopaminergic Therapeutic StrategiesPharmacotherapyCannabinoid PharmacologySocial SciencesNeuroinflammation	2014	37

Page 1